PE20011180A1 - Vacuna contra la salmonella materiales y metodos - Google Patents
Vacuna contra la salmonella materiales y metodosInfo
- Publication number
- PE20011180A1 PE20011180A1 PE2001000253A PE2001000253A PE20011180A1 PE 20011180 A1 PE20011180 A1 PE 20011180A1 PE 2001000253 A PE2001000253 A PE 2001000253A PE 2001000253 A PE2001000253 A PE 2001000253A PE 20011180 A1 PE20011180 A1 PE 20011180A1
- Authority
- PE
- Peru
- Prior art keywords
- nucleotides
- salmonella
- sequences
- ssat
- region
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA VACUNA QUE CONTIENE UNA CANTIDAD INMUNOLOGICAMENTE PROTECTORA DE SALMONELLA MUTANTE INCAPAZ DE REVERTIR, EN LA QUE SE HA INACTIVADO DOS O MAS GENES DENTRO DE LA REGION ISLA DE PATOGENICIDAD 2 EN SALMONELLA (IP2S); POR SUPRESION DE UNA PORCION DE LA REGION CODIFICANTE DEL GEN DEL APARATO DEL SISTEMA DE SECRECION SSA SELECCIONANDOSE DE SSAT QUE PRESENTA 779 NUCLEOTIDOS, SSAJ DE 749 NUCLEOTIDOS, SSAC DE 1052 NUCLEOTIDOS, SSAM DE 368 NUCLEOTIDOS O EL TRAMO COMPLETO DE LAS SECUENCIAS DE NUCLEOTIDOS QUE SE HIBRIDIZA CON EL COMPLEMENTO NO CODIFICANTE DE LA SECUENCIA DE DICHAS SECUENCIAS DE NUCLEOTIDOS, EN CONDICIONES RIGUROSAS, O UN TRAMO COMPLETO DE LAS SECUENCIAS DE NUCLEOTIDOS DE SALMONELLA QUE POSEE 95% DE IDENTIDAD DE LAS SECUENCIAS DE SSAT, SSAJ, SSAC, SSAM; O MEDIANTE MUTACION POR INSERCION. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE ADEMAS UNA SEGUNDA SALMONELLA MUTANTE ATENUADA EN LA QUE SE HAN INACTIVADO UNO O MAS GENES DENTRO DE LA REGION IP2S; QUE SE CARACTERIZAN POR PERTENECER A SEROTIPOS DIFERENTES COMO SALMONELLA ENTERICA, S. DUBLIN, S.TYPHIMURIUM SUBESPECIE ENTERICA O CUALQUIERA DE LOS SIGUIENTES SEROGRUPOS A, B, C1, C2, D1, E1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19017800P | 2000-03-17 | 2000-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20011180A1 true PE20011180A1 (es) | 2001-11-15 |
Family
ID=22700305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000253A PE20011180A1 (es) | 2000-03-17 | 2001-03-16 | Vacuna contra la salmonella materiales y metodos |
Country Status (17)
Country | Link |
---|---|
US (2) | US6923957B2 (es) |
EP (1) | EP1267899B1 (es) |
JP (1) | JP2003527433A (es) |
AR (1) | AR027680A1 (es) |
AT (1) | ATE300949T1 (es) |
AU (2) | AU5695701A (es) |
BR (1) | BR0109322A (es) |
CA (1) | CA2402252A1 (es) |
DE (1) | DE60112413T2 (es) |
DK (1) | DK1267899T3 (es) |
ES (1) | ES2244617T3 (es) |
MX (1) | MXPA02008748A (es) |
NZ (1) | NZ521425A (es) |
PE (1) | PE20011180A1 (es) |
PT (1) | PT1267899E (es) |
WO (1) | WO2001070247A2 (es) |
ZA (1) | ZA200207002B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE300949T1 (de) * | 2000-03-17 | 2005-08-15 | Pharmacia & Upjohn Co Llc | Ssa inaktivierte salmonella impfstoffe |
AU2004204751A1 (en) * | 2003-01-09 | 2004-07-29 | The Trustees Of The University Of Pennsylvania | Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
CN1297315C (zh) * | 2004-11-25 | 2007-01-31 | 上海交通大学 | 抗仔猪细菌性疫病复合卵黄抗体制剂的制备方法 |
EP1882036B1 (en) * | 2005-05-17 | 2012-02-15 | Ozgene Pty Ltd | Sequential cloning system |
US20070191736A1 (en) * | 2005-10-04 | 2007-08-16 | Don Alden | Method for loading penetrating members in a collection device |
CN101522210B (zh) | 2006-09-18 | 2017-03-22 | 阿肯色大学评议会 | 增强免疫应答的组合物和方法 |
UA100370C2 (uk) * | 2006-12-11 | 2012-12-25 | Мериал Лимитед | Спосіб вакцинації птахів проти salmonella |
US20080260777A1 (en) * | 2007-04-19 | 2008-10-23 | Sotomayor Konky | Composition and method for controlling intestinal pathogenic organisms |
US7935355B2 (en) * | 2007-04-19 | 2011-05-03 | Nutritional Health Institute Laboratories, Llc | Composition and method for controlling intestinal pathogenic organisms |
WO2009059018A1 (en) * | 2007-10-30 | 2009-05-07 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to flagellated bacterium |
HUE047164T2 (hu) | 2007-11-01 | 2020-04-28 | Univ Arkansas | Kompozíciók és eljárások eimeria elleni immunválasz fokozására |
EP2217716A4 (en) | 2007-11-09 | 2011-02-09 | Salk Inst For Biological Studi | USE OF TAM RECEPTOR INHIBITORS AS ANTIMICROBIAL AGENTS |
NO2525817T3 (es) | 2010-01-21 | 2018-01-06 | ||
CN102971008B (zh) | 2010-06-09 | 2015-11-25 | 阿肯色大学评议会 | 降低弯曲菌属感染的疫苗和方法 |
WO2012123269A1 (en) | 2011-03-11 | 2012-09-20 | Proyecto De Biomedicina Cima, S.L. | Immunogenic compositions and methods for their use |
US8481052B2 (en) | 2011-05-17 | 2013-07-09 | Cj Cheiljedang Corporation | Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same |
US9950053B2 (en) | 2012-10-22 | 2018-04-24 | The Board Of Regents For Oklahoma State University | Use of the Salmonella SPP type III secretion proteins as a protective vaccination |
US10548962B2 (en) | 2012-10-22 | 2020-02-04 | The Board Of Regents For Oklahoma State University | Use of the salmonella SPP type III secretion proteins as a protective vaccination |
US20150238590A1 (en) * | 2012-10-22 | 2015-08-27 | The Board Of Regents For Oklahoma State University | Use of the salmonella spp type iii secretion proteins as a protective vaccination |
KR102228324B1 (ko) | 2013-02-14 | 2021-03-15 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 에이메리아에 대한 면역 반응을 증진시키거나, 에이메리아 감염을 제한하는 조성물 및 방법 |
KR102239207B1 (ko) | 2013-03-15 | 2021-04-09 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 장내 병원균에 대한 면역 반응을 증진시키는 조성물 및 방법 |
WO2016077453A1 (en) * | 2014-11-11 | 2016-05-19 | Ohio State Innovation Foundation | Probiotic bacteria for the prevention and treatment of salmonella |
US20170072042A1 (en) * | 2015-09-16 | 2017-03-16 | Boehringer Ingelheim Vetmedica, Inc. | Salmonella choleraesuis-salmonella typhimurium vaccines |
WO2017192671A1 (en) | 2016-05-03 | 2017-11-09 | The Board Of Trustees Of The University Of Arkansas | Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
US4877612A (en) | 1985-05-20 | 1989-10-31 | Frank M. Berger | Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process |
EP0231039B1 (en) | 1986-01-14 | 1992-01-08 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | Process for preparing immunological complexes and pharmaceutical composition containing these complexes |
US4806352A (en) | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
NZ296581A (en) | 1994-12-09 | 2000-02-28 | Imp College Innovations Ltd | A method of identifying genes identified in a microorganisms ability to adapt to changes in its environment |
JP2002524077A (ja) * | 1998-09-04 | 2002-08-06 | クリートゲン アクチエンゲゼルシャフト | 抗原キャリヤーとしての弱毒化サルモネラspi2突然変異体 |
NZ519477A (en) * | 1999-12-23 | 2004-04-30 | Microscience Ltd | Attenuated microorganisms for the treatment of infection |
ATE300949T1 (de) * | 2000-03-17 | 2005-08-15 | Pharmacia & Upjohn Co Llc | Ssa inaktivierte salmonella impfstoffe |
-
2001
- 2001-03-13 AT AT01930419T patent/ATE300949T1/de not_active IP Right Cessation
- 2001-03-13 DK DK01930419T patent/DK1267899T3/da active
- 2001-03-13 DE DE60112413T patent/DE60112413T2/de not_active Expired - Fee Related
- 2001-03-13 PT PT01930419T patent/PT1267899E/pt unknown
- 2001-03-13 BR BR0109322-3A patent/BR0109322A/pt not_active IP Right Cessation
- 2001-03-13 EP EP01930419A patent/EP1267899B1/en not_active Expired - Lifetime
- 2001-03-13 JP JP2001568444A patent/JP2003527433A/ja active Pending
- 2001-03-13 WO PCT/US2001/008042 patent/WO2001070247A2/en active IP Right Grant
- 2001-03-13 ES ES01930419T patent/ES2244617T3/es not_active Expired - Lifetime
- 2001-03-13 AU AU5695701A patent/AU5695701A/xx active Pending
- 2001-03-13 AU AU2001256957A patent/AU2001256957B2/en not_active Ceased
- 2001-03-13 MX MXPA02008748A patent/MXPA02008748A/es not_active Application Discontinuation
- 2001-03-13 CA CA002402252A patent/CA2402252A1/en not_active Abandoned
- 2001-03-13 NZ NZ521425A patent/NZ521425A/en unknown
- 2001-03-15 US US09/809,524 patent/US6923957B2/en not_active Expired - Fee Related
- 2001-03-16 PE PE2001000253A patent/PE20011180A1/es not_active Application Discontinuation
- 2001-03-19 AR ARP010101274A patent/AR027680A1/es unknown
-
2002
- 2002-08-30 ZA ZA200207002A patent/ZA200207002B/xx unknown
-
2005
- 2005-03-18 US US11/084,711 patent/US20050260223A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR0109322A (pt) | 2002-12-10 |
ATE300949T1 (de) | 2005-08-15 |
DK1267899T3 (da) | 2005-12-12 |
US6923957B2 (en) | 2005-08-02 |
US20040009191A1 (en) | 2004-01-15 |
EP1267899A2 (en) | 2003-01-02 |
ZA200207002B (en) | 2004-03-31 |
EP1267899B1 (en) | 2005-08-03 |
CA2402252A1 (en) | 2001-09-27 |
PT1267899E (pt) | 2005-11-30 |
WO2001070247A3 (en) | 2002-04-18 |
JP2003527433A (ja) | 2003-09-16 |
AR027680A1 (es) | 2003-04-09 |
WO2001070247A2 (en) | 2001-09-27 |
MXPA02008748A (es) | 2003-02-24 |
AU5695701A (en) | 2001-10-03 |
DE60112413T2 (de) | 2006-06-01 |
US20050260223A1 (en) | 2005-11-24 |
NZ521425A (en) | 2004-05-28 |
ES2244617T3 (es) | 2005-12-16 |
DE60112413D1 (de) | 2005-09-08 |
AU2001256957B2 (en) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20011180A1 (es) | Vacuna contra la salmonella materiales y metodos | |
ES2156110T3 (es) | Analogos de sub-unidades de toxina del colera derivados de adn recombinante. | |
Mulder et al. | Identification of additional virulence determinants on the pYV plasmid of Yersinia enterocolitica W227 | |
ES2181306T3 (es) | Vacunas recombinantes que comprenden bacterias atenuadas inmunogenicas que tienen fenotipo rpos positivo. | |
PT672116E (pt) | Mutantes por supressao como vacinas contra a colera | |
CL2008003202A1 (es) | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. | |
UA98812C2 (ru) | Авирулентная активированная живая вакцина mycoplasma hyopneumoniae | |
Preethee et al. | Molecular identification of an Enterococcus faecalis endocarditis antigen efaA in root canals of therapy-resistant endodontic infections | |
AR044696A1 (es) | Composicion de vacunas | |
Iskra-Caruana et al. | The common evolutionary history of badnaviruses and banana | |
BR0010418A (pt) | Microorganismos atenuados para o tratamento de infecção | |
Damé-Teixeira et al. | Genotypic diversity and virulence traits of Streptococcus mutans isolated from carious dentin after partial caries removal and sealing | |
Pereira et al. | Molecular characterization of feline calicivirus variants from multicat household and public animal shelter in Rio de Janeiro, Brazil | |
Raviv et al. | Strain differentiating real-time PCR for Mycoplasma gallisepticum live vaccine evaluation studies | |
DK1154791T3 (da) | Neisseria-vaccinesammensætninger og fremgangsmåder | |
CL2023001826A1 (es) | Eliminación genómica en la vacuna contra la peste porcina africana que permite un crecimiento eficaz en estirpes celulares estables | |
Bertone et al. | Genetic-relatedness of peri-implants and buccal Candida albicans isolates determined by RAPD-PCR | |
TR200002974T2 (tr) | Bruselloza karşı canlı aşı | |
Bedford et al. | Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions | |
HUP0303878A2 (hu) | Himlő elleni vakcina | |
ES2054230T3 (es) | Un proceso para la preparacion de un enterovirus o rinovirus atenuado. | |
Sánchez-Jiménez et al. | Distribution of pathogenicity islands among Colombian isolates of Salmonella | |
ES2120989T3 (es) | Vector virico recombinante de tipo varicela-zoster. | |
HUP9702355A2 (hu) | Avirulens Mycoplasma synoviae, és az ezt tartalmazó vakcina | |
Leal et al. | RAPD-PCR typing of Yersinia enterocolitica (Enterobacteriaceae) O: 3 serotype strains isolated from pigs and humans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |